Castle Biosciences Inc. (CSTL) Prices 2M Share Common Offering at $37/Sh

Castle Biosciences, Inc. (NASDAQ: CSTL), announced today the pricing of its underwritten public offering of 2,000,000 shares of its common stock at a price to the public of $37.00 per share. The gross proceeds to Castle Biosciences from the offering, before deducting the underwriting discounts and commissions and offering expenses, are expected to be $74.0 million. In addition, Castle Biosciences has granted the underwriters a 30-day option to purchase up to an additional 300,000 shares of common stock at the offering price, less the underwriting discounts and commissions. The offering is expected to close on June 29, 2020, subject to customary closing conditions.

SVB Leerink and Baird are joint book-running managers for the offering and representatives of the underwriters. Canaccord Genuity is a passive book-runner and BTIG is a co-manager for the offering.

You May Also Be Interested In

• Castle Biosciences wins New York approval for atopic dermatitis test
• Tailored Brands files for IPO, plans Nasdaq listing under MENW
• Fiserv (FISV) PT Lowered to $62 at Baird, 'designating as a bearish Fresh Pick into earnings'